Combination of technologies for Drug Development and Biomarker Discovery.
ImaBiotech develops and integrates recent technologies to study the distribution of drug and biomarkers simultaneously. This integration of innovative imaging technologies allow to measure and quantify the impact of drugs to cells and the tissue microenvironment. We decipher the complexity of the tissue and allows to depict the full picture of the efficacy of a drug or the relevance of a biomarker.
The multimodal imaging platform and image analysis includes:
- Different Mass Spectrometry Imaging Capabilities (Learn More)
- GeoMx Spatially resolved Gene expression (Learn More)
- Laser Capture Microdissection (Learn More)
- Digital pathology (Learn More)
- Multimaging Software solutions (Learn More)
- Hyperion Fluidigm High Multiplex IHC (Learn More)
- Exclusive Panel of Biomarkers (Create your own panel)
With the integration of innovative spatially resolved technologies, we offer a wide ran of services that includes: